GlassScriptPhysician profile
Philip L Smith
NPI 1184690877
$664.89
in general payments reported to CMS, 2019-2025
13 companies · $15.90 in 2025
The $15.90 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2021: $191 · 2022: $57.33 · 2024: $162 · 2025: $15.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $125.34 | 2024 | Ahmed Glaucoma Valve, Clearpath, Kahook Dual Blade |
| Sun Pharmaceutical Industries INC. | $96.57 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $90.46 | 2019-2021 | |
| Alcon Vision LLC | $71.01 | 2019-2025 | Precision 1 |
| Akorn Operating Company LLC | $43.13 | 2021 | |
| Novartis Pharmaceuticals Corporation | $43.09 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $38.27 | 2019-2021 | |
| Dompe US, INC. | $36.56 | 2024 | Oxervate |
| Shire North American Group INC | $32.28 | 2019 | |
| Oyster Point Pharma, INC. | $31.86 | 2022 | |
| Allergan, INC. | $25.72 | 2021 | |
| Kala Pharmaceuticals, INC. | $15.93 | 2021 | |
| Aerie Pharmaceuticals, INC. | $14.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.